tirzepatide men 🧬 New research presented at the Endocrine Society's 2025 meeting reveals that GLP-1 medications—like semaglutide (Ozempic), dulaglutide (Trulicity), and (Mounjaro)—may do more than support weight loss and blood sugar control. These Target-Adults Strengths:60 mg pfizer glp-1 agonist Acquires

tirzepatide men 🧬 New research presented at the Endocrine Society's 2025 meeting reveals that GLP-1 medications—like semaglutide (Ozempic), dulaglutide (Trulicity), and (Mounjaro)—may do more than support weight loss and blood sugar control. These Target-Adults Strengths:60 mg pfizer glp-1 agonist Acquires

pfizer glp-1 agonist Acquires a Pipeline and Revives FOMO Corporate Strategy Pharma News | Immutep, Pfizer, –

Edoardo Zancanaro Julia Grapsa Sara Moscatelli Victoria Delgado Ignatios Ikonomidis John Thymis Georgios Georgiopoulos Steffen Petersen Denisa Muraru #Cardiology #Diabetes #CardioMetabolic #Echocardiography #GLP1 #SGLT2 #CardiovascularImaging #HeartFailure #StrainImaging #Prevention To view or add a comment, sign in New research indicates popular GLP‑1 weight‑loss medications, including semaglutide (Ozempic/Wegovy), are linked to lower risk of heart attack and stroke

Target-Adults

Strengths:60 mg

If you experience worsening depression, new suicidal thoughts, increased anxiety, or emotional numbness after starting tirzepatide, contact your prescriber immediately—this may signal the need for an antidepressant dose adjustment, not tirzepatide discontinuation